Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial

Autor: Zhang, Tian, Howard, Lauren, Koontz, Bridget F., Tagawa, Scott T., Nagar, Himanshu, Bitting, Rhonda L., Frizzell, Bart A., Nordquist, Luke, Rasmussen, Julia, Riggan, Colleen, Reyes, Marco, Davies, Catrin, Gray, Steven R., Newman, Carly R., Fernandez, Escarleth, Ramalingam, Sundhar, Harrison, Michael R., George, Daniel J., Wu, Yuan, Armstrong, Andrew J.
Zdroj: In European Urology Oncology June 2024
Databáze: ScienceDirect
Externí odkaz: